Background: Some studies suggest that low-frequency transcranial ultrasound (LFTUS) can enhance thrombolysis, but other studies suggest that it may have adverse effects on intracranial tissues. We previously reported that LFTUS with appropriate parameters was effective and safe in a normotensive rat model of thromboembolic middle cerebral artery occlusion (MCAO) stroke. The goal of this study was to test the safety of this strategy in a spontaneously hypertensive rat (SHR) model of permanent MCAO. Methods: Right MCAO was achieved in male SHRs using intraluminal nylon sutures. Rats exhibiting left hemiparesis were randomly assigned to one of four different groups: (1) normal saline (NS) group (n = 8), intravenous administration of NS as placebo at 3 h after MCAO; (2) NS+LFTUS group (n = 10), NS administration with simultaneous application of LFTUS (480.4 kHz, continuous wave, at an intensity of 0.3 W/cm2) for 1 h; (3) tissue plasminogen activator (tPA) group (n = 11), intravenous administration of alteplase (10 mg/kg body weight) over 1 h instead of NS; or (4) tPA+LFTUS group (n = 11), tPA administration and application of LFTUS. Twenty-four hours after treatment, neurological change was evaluated, and brains were removed and examined histologically. Results: There was no significant difference (p > 0.09) when comparing changes in neurologic status and body weight, infarct ratio, edema ratio, or hemorrhagic transformation among the four groups. Conclusions: Our findings suggest that sonothrombolytic treatment with LFTUS with appropriate parameters is safe when used for the treatment of ischemic stroke in hypertensive rats under the undesired permanent MCAO condition.

Keywords:
Acute stroke, Cerebral ischemia, Experimental stroke research, Intracranial hemorrhage, Hypertension, Thrombolysis, Ultrasound
1.
Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye LA, Hill MD, Wojner AW, CLOTBUST Investigators: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170–2178.
2.
Cintas P, Le Traon AP, Larrue V: High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke 2002;33:626–628.
3.
Holscher T, Raman R, Ernström K, Parrish J, Le DT, Lyden PD, Mattrey RF: In vitro sonothrombolysis with duplex ultrasound: first results using a simplified model. Cerebrovasc Dis 2009;28:365–370.
4.
Meairs S, Culp W: Microbubbles for thrombolysis of acute ischemic stroke. Cerebrovasc Dis 2009;27(suppl 2):55–65.
5.
Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, Arenillas JF, Huertas R, Purroy F, Delgado P, Alvarez-Sabin J: Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006;37:425–429.
6.
Molina CA, Alvarez-Sabín J: Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 2009;27(suppl 1): 162–167.
7.
Nedelmann M, Eicke BM, Lierke EG, Heimann A, Kempski O, Hopf HC: Low-frequency ultrasound induces nonenzymatic thrombolysis in vitro. J Ultrasound Med 2002;21:649–656.
8.
Suchkova V, Carstensen EL, Francis CW: Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz. Ultrasound Med Biol 2002;28:377–382.
9.
Daffertshofer M, Huang Z, Fatar M, Popolo M, Schroeck H, Kuschinsky W, Moskowitz MA, Hennerici MG: Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke. Neurosci Lett 2004;361:115–119.
10.
Wang Z, Moehring MA, Voie AH, Furuhata H: In vitro evaluation of dual mode ultrasonic thrombolysis method for transcranial application with an occlusive thrombosis model. Ultrasound Med Biol 2008;34:96–102.
11.
Akiyama M, Ishibashi T, Yamada T, Furuhata H: Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery 1998;43:828–832.
12.
Behrens S, Daffertshofer M, Spiegel D, Hennerici M: Low-frequency, low intensity ultrasound accelerates thrombolysis through the skull. Ultrasound Med Biol 1999;25:269–273.
13.
Behrens S, Spengos K, Daffertshofer M, Schroeck H, Dempfle CE, Hennerici M: Transcranial ultrasound-improved thrombolysis: diagnostic vs. therapeutic ultrasound. Ultrasound Med Biol 2001;27:1683–1689.
14.
Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, Sedlaczek O, Koroshetz WJ, Hennerici MG: Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 2005;36:1441–1446.
15.
Schneider F, Gerriets T, Walberer M, Mueller C, Rolke R, Eicke BM, Bohl J, Kempski O, Kaps M, Bachmann G, Dieterich M, Nedelmann M: Brain edema and intracerebral necrosis caused by transcranial low-frequency 20-kHz ultrasound: a safety study in rats. Stroke 2006;37:1301–1306.
16.
Reinhard M, Hetzel A, Kruger S, Kretzer S, Talazko J, Ziyeh S, Weber J, Els T: Blood-brain barrier disruption by low-frequency ultrasound. Stroke 2006;37:1546–1548.
17.
Fatar M, Stroick M, Griebe M, Alonso A, Hennerici MG, Daffertshofer M: Brain temperature during 340-kHz pulsed ultrasound insonation: a safety study for sonothrombolysis. Stroke 2006;37:1883–1887.
18.
Reuter P, Masomi J, Kuntze H, Fischer I, Helling K, Sommer C, Alessandri B, Heimann A, Gerriets T, Marx J, Kempski O, Nedelmann M: Low-frequency therapeutic ultrasound with varied duty cycle: effects on the ischemic brain and the inner ear. Ultrasound Med Biol 2010;36:1188–1195.
19.
Saguchi T, Onoue H, Urashima M, Ishibashi T, Abe T, Furuhata H: Effective and safe conditions of low-frequency transcranial ultrasonic thrombolysis for acute ischemic stroke: neurologic and histologic evaluation in a rat middle cerebral artery stroke model. Stroke 2008;39:1007–1011.
20.
O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S, INTERSTROKE Investigators: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112–123.
21.
Koizumi J, Yoshida Y, Nakazawa T, Ooneda G: Experimental studies of ischemic brain edema I. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986;8:1–8.
22.
Menzies SA, Hoff JT, Betz AL: Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992;31:100–106.
23.
Korninger C, Collen D: Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 1981;46:561–565.
24.
Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR: A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290–293.
25.
Lu A, Clark JF, Broderick JP, Pyne-Geithman GJ, Wagner KR, Khatri P, Tomsick T, Sharp FR: Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp Neurol 2009;216:407–412.
26.
Zhang L, Zhang ZG, Zhang RL, Lu M, Krams M, Chopp M: Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 2003;34:1790–1795.
27.
Sare GM, Geeganage C, Bath PM: High blood pressure in acute ischaemic stroke – broadening therapeutic horizons. Cerebrovasc Dis 2009;27(suppl 1):156–161.
28.
Gautier S, Petrault O, Gele P, Laprais M, Bastide M, Bauters A, Deplanque D, Jude B, Caron J, Bordet R: Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function. Stroke 2003;34:2975– 2979.
29.
Apfel RE, Holland CK: Gauging the likelihood of cavitation from short pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 1991;17:179–185.
30.
Azuma T, Kawabata K, Umemura S, Ogihara M, Kubota J, Sasaki A, Furuhata H: Bubble generation by standing wave in water surrounded by cranium with transcranial ultrasonic beam. Jpn J Appl Physics 2005;44:4625–4630.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.